ClinicalTrials.govpublic full text
A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer
acute myeloid leukemia (aml), relapsed/refractory acute myeloid leukemia, dose-limiting toxicity, recommended phase two dose, pharmacokinetics, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 802166
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.